Skip to main content
NCBI home page
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1960 Apr 9;82(15):759–766.

The Present Status of Oral Vaccination against Poliomyelitis and Future Problems

C E van Rooyen, R L Ozere
PMCID: PMC1938009  PMID: 13841138

Full text

PDF
759

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bernstein H. G., Clark J. M., Tunbridge R. E. Acute Anterior Poliomyelitis among Service Personnel in Malta. Br Med J. 1945 Jun 2;1(4404):763–767. doi: 10.1136/bmj.1.4404.763. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. DALLDORF G., WEIGAND H. Poliomyelitis as a complex infection. J Exp Med. 1958 Nov 1;108(5):605–616. doi: 10.1084/jem.108.5.605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. DAVIS D. C., MELNICK J. L. Two additional examples of viremia in asymptomatic poliomyelitis infection. Pediatrics. 1957 Dec;20(6):975–978. [PubMed] [Google Scholar]
  4. DULBECCO R., VOGT M. Plaque formation and isolation of pure lines with poliomyelitis viruses. J Exp Med. 1954 Feb;99(2):167–182. doi: 10.1084/jem.99.2.167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Enders J. F., Weller T. H., Robbins F. C. Cultivation of the Lansing Strain of Poliomyelitis Virus in Cultures of Various Human Embryonic Tissues. Science. 1949 Jan 28;109(2822):85–87. doi: 10.1126/science.109.2822.85. [DOI] [PubMed] [Google Scholar]
  6. FENNER F. Myxomatosis. Br Med Bull. 1959 Sep;15:240–245. doi: 10.1093/oxfordjournals.bmb.a069772. [DOI] [PubMed] [Google Scholar]
  7. FOX J. P., GELFAND H. M., LEBLANC D. R., CONWELL D. P. Studies on the development of natural immunity to poliomyelitis in Louisiana. I. Over-all plan, methods and observations as to patterns of seroimmunity in the study group. Am J Hyg. 1957 May;65(3):344–366. doi: 10.1093/oxfordjournals.aje.a119874. [DOI] [PubMed] [Google Scholar]
  8. GARD S. Immuno-inactivation of poliovirus. Arch Gesamte Virusforsch. 1957;7(5):449–460. doi: 10.1007/BF01241961. [DOI] [PubMed] [Google Scholar]
  9. GELFAND H. M., POTASH L., LEBLANC D. R., FOX J. P. Intrafamilial and interfamilial spread of living vaccine strains of polioviruses. J Am Med Assoc. 1959 Aug 22;170(17):2039–2048. doi: 10.1001/jama.1959.03010170001001. [DOI] [PubMed] [Google Scholar]
  10. HORSTMANN D. M., NIEDERMAN J. C., MELNICK J. L., PAUL J. R. Poliomyelitis: comparison of responses of vaccinated and naturally immune humans to ingestion of attenuated poliovirus. Trans Assoc Am Physicians. 1957;70:91–101. [PubMed] [Google Scholar]
  11. HORSTMANN D. M., PAUL J. R., MELNICK J. L., DEUTSCH J. V. Infection induced by oral administration of attenuated poliovirus to persons possessing homotypic antibody. J Exp Med. 1957 Jul 1;106(1):159–177. doi: 10.1084/jem.106.1.159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. ISAACS A., BURKE D. C. Viral interference and interferon. Br Med Bull. 1959 Sep;15:185–188. doi: 10.1093/oxfordjournals.bmb.a069760. [DOI] [PubMed] [Google Scholar]
  13. KANDA Y., MELNICK J. L. In vitro differentiation of virulent and attenuated polioviruses by their growth characteristics on MS cells. J Exp Med. 1959 Jan 1;109(1):9–24. doi: 10.1084/jem.109.1.9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. KOPROWSKI H., NORTON T. W., JERVIS G. A., NELSON T. L., CHADWICK D. L., NELSEN D. J., MEYER K. F. Clinical investigations on attenuated strains of poliomyelitis virus; use as a method of immunization of children with living virus. J Am Med Assoc. 1956 Mar 17;160(11):954–966. doi: 10.1001/jama.1956.02960460032008. [DOI] [PubMed] [Google Scholar]
  15. KUBRYK D. Paralytic polimyelitis trends, Canada, 1958. Can Med Assoc J. 1959 Aug 15;81:228–231. [PMC free article] [PubMed] [Google Scholar]
  16. LENNETTE E. H., MAGOFFIN R. L., SCHMIDT N. J., HOLLISTER A. C., Jr Viral disease of the central nervous system; influence of poliomyelitis vaccination on etiology. J Am Med Assoc. 1959 Nov 14;171:1456–1464. doi: 10.1001/jama.1959.03010290014006. [DOI] [PubMed] [Google Scholar]
  17. LWOFF A., LWOFF M. Remarques sur les facteurs aspécifiques gouvernant l'évolution des infections virales; la notion d'état critique. C R Hebd Seances Acad Sci. 1959 Jan 5;248(1):154–156. [PubMed] [Google Scholar]
  18. MELNICK J. L., LEDINKO N. Development of neutralizing antibodies against the three types of poliomyelitis virus during an epidemic period; the ratio of inapparent infection to clinical poliomyelitis. Am J Hyg. 1953 Sep;58(2):207–222. doi: 10.1093/oxfordjournals.aje.a119602. [DOI] [PubMed] [Google Scholar]
  19. McBRIDE W. D. Antigenic analysis of polioviruses by kinetic studies of serum neutralization. Virology. 1959 Jan;7(1):45–58. doi: 10.1016/0042-6822(59)90176-x. [DOI] [PubMed] [Google Scholar]
  20. PAUL J. R., RIORDAN J. R. Observations on serological epidemiology antibodies to the Lansing strain of poliomyelitis virus in sera from Alaskan eskimos. Am J Hyg. 1950 Sep;52(2):202–212. [PubMed] [Google Scholar]
  21. PEART A. F. W., RHODES A. J. An outbreak of poliomyelitis in Canadian Eskimos in wintertime. Can J Public Health. 1949 Oct;40(10):405–419. [PubMed] [Google Scholar]
  22. PLOTKIN S. A., KOPROWSKI H., STOKES J., Jr Clinical trials in infants of orally administered attenuated poliomyelitis viruses. Pediatrics. 1959 Jun;23(6):1041–1062. [PubMed] [Google Scholar]
  23. VOGT M., DULBECCO R., WENNER H. A. Mutants of poliomyelitis viruses with reduced efficiency of plating in acid medium and reduced neuropathogenicity. Virology. 1957 Aug;4(1):141–155. doi: 10.1016/0042-6822(57)90050-8. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES